Constantine GD - Search Results

1

Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial.

Simon JA, Archer DF, Kagan R, Bernick B, Graham S, Constantine GD, Mirkin S. Simon JA, et al. Among authors: constantine gd. Menopause. 2017 Sep;24(9):1003-1010. doi: 10.1097/GME.0000000000000880. Menopause. 2017. PMID: 28419068 Free PMC article. Clinical Trial.

2

TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.

Simon JA, Kagan R, Archer DF, Constantine GD, Bernick B, Graham S, Mirkin S. Simon JA, et al. Among authors: constantine gd. Climacteric. 2019 Aug;22(4):412-418. doi: 10.1080/13697137.2019.1577379. Epub 2019 Mar 12. Climacteric. 2019. PMID: 30862193 Clinical Trial.

3

Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal women.

Kagan R, Constantine G, Kaunitz AM, Bernick B, Mirkin S. Kagan R, et al. Menopause. 2018 Dec 21;26(6):622-628. doi: 10.1097/GME.0000000000001278. Menopause. 2018. PMID: 30586005 Free PMC article. Clinical Trial.

4

Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia.

Constantine G, Millheiser LS, Kaunitz AM, Parish SJ, Graham S, Bernick B, Mirkin S. Constantine G, et al. Menopause. 2019 Nov;26(11):1259-1264. doi: 10.1097/GME.0000000000001394. Menopause. 2019. PMID: 31688572 Clinical Trial.

5

Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms.

McClung MR, Kagan R, Graham S, Bernick B, Mirkin S, Constantine G. McClung MR, et al. Menopause. 2022 Feb 14;29(3):304-308. doi: 10.1097/GME.0000000000001915. Menopause. 2022. PMID: 35213517 Free PMC article. Clinical Trial.

6

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.

Archer DF, Pinkerton JV, Utian WH, Menegoci JC, de Villiers TJ, Yuen CK, Levine AB, Chines AA, Constantine GD. Archer DF, et al. Among authors: constantine gd. Menopause. 2009 Nov-Dec;16(6):1109-15. doi: 10.1097/gme.0b013e3181a818db. Menopause. 2009. PMID: 19543129 Clinical Trial.

7

Endometrial safety of ospemifene: results of the phase 2/3 clinical development program.

Constantine GD, Goldstein SR, Archer DF. Constantine GD, et al. Menopause. 2015 Jan;22(1):36-43. doi: 10.1097/GME.0000000000000275. Menopause. 2015. PMID: 24977459 Free PMC article. Clinical Trial.

8

Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence.

Archer DF, Carr BR, Pinkerton JV, Taylor HS, Constantine GD. Archer DF, et al. Among authors: constantine gd. Menopause. 2015 Jul;22(7):786-96. doi: 10.1097/GME.0000000000000365. Menopause. 2015. PMID: 25423325 Free PMC article. Review.

9

Effects of ospemifene on bone parameters including clinical biomarkers in postmenopausal women.

Constantine GD, Kagan R, Miller PD. Constantine GD, et al. Menopause. 2016 Jun;23(6):638-44. doi: 10.1097/GME.0000000000000619. Menopause. 2016. PMID: 27045700 Review.

10

Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical data.

Constantine GD, Archer DF, Pollycove R, Jiang W, Altomare C, Pinkerton JV. Constantine GD, et al. Menopause. 2016 Sep;23(9):957-64. doi: 10.1097/GME.0000000000000656. Menopause. 2016. PMID: 27404027 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page